INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 46 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $45,000 | -22.4% | 83,995 | +10.9% | 0.00% | – |
| Q4 2017 | $58,000 | -31.0% | 75,720 | +31.2% | 0.00% | – |
| Q3 2017 | $84,000 | -9.7% | 57,719 | +67.4% | 0.00% | – |
| Q2 2017 | $93,000 | -27.3% | 34,487 | +8.9% | 0.00% | – |
| Q1 2017 | $128,000 | -19.5% | 31,681 | -16.5% | 0.00% | – |
| Q4 2016 | $159,000 | -47.5% | 37,958 | -14.8% | 0.00% | – |
| Q3 2016 | $303,000 | -6.2% | 44,574 | -20.3% | 0.00% | – |
| Q2 2016 | $323,000 | +9.9% | 55,946 | +33.0% | 0.00% | – |
| Q1 2016 | $294,000 | +4.6% | 42,055 | +7.6% | 0.00% | – |
| Q4 2015 | $281,000 | -15.9% | 39,098 | +0.9% | 0.00% | – |
| Q3 2015 | $334,000 | +11.0% | 38,744 | +107.7% | 0.00% | – |
| Q2 2015 | $301,000 | – | 18,655 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|